Welcome to CEBD

Cochrane Skin is a network of people from all over the world committed to producing and updating systematic reviews of trials relating to skin conditions. Its editorial base was located at the CEBD until April 2023, at which point it moved to France. Its output regularly informs other strands of work such as the need for new trials and the best design of new trials. The scope of Cochrane Skin is wide, and includes any skin problem that leads an individual to seek help from a health care provider. They also consider evidence about skin treatments that are sold over-the-counter or are widely available.

The Harmonizing Outcome Measures for Eczema (HOME) initiative was founded in 2008 by Professor Hywel Williams (UK) and Jochen Schmitt (Germany) in response to the use of multiple unvalidated outcome measures in eczema trials. HOME aims to agree a set of core outcome measures for atopic eczema which should be included in all clinical trials and clinical record-keeping to allow comparison of data across multiple trials.

The UK Dermatology Clinical Trials Network (UK DCTN) is a dermatology clinical trials network open to anyone with an interest in applied dermatological research. The Network was developed in 2002 by Professor Hywel Williams and a group of academic and clinical colleagues in response to the growing need for high quality evidence to inform dermatology clinical practice. The UK DCTN has now developed into a collaborative, national network of dermatologists, nurses, health service researchers and patient representatives.

Professor Jochen Schmitt and Professor Hywel Williams initiated the Cochrane Skin - Core Outcome Set Initiative (CS-COUSIN) whose mission was "to develop and implement core outcome sets in dermatology in order to improve and standardise outcome measurement in clinical trials and to make trial evidence more useful." CS-COUSIN has joined with the Consortium for Harmonizing Outcomes Research in Dermatology (CHORD) that has brought together a global network of stakeholders engaged in core outcome set (COS) development for dermatologic conditions under one organizational structure known as C3: CHORD COUSIN Collaboration. C3’s vision is the improved health of patients through robust assessment of interventions in dermatology, skin care and related areas. The mission is to develop, disseminate and implement Core Outcome Sets (COS) for clinical trials and routine care through the engagement of patients, clinical experts, methodologists, industry partners and other possible stakeholders.

The aim of the  Society for Academic Primary Care Skin research Specialist Interest Group is to promote research into the diagnosis and management of the skin problems commonly seen in primary care, through networking, collaboration, and on-line discussion.

A new research network in the Faculty of Medicine and Health Sciences: the University of Nottingham Global Evidence Network for Health (UoN-GEN4Health). The University is unique in hosting ‘Evidence Centres’ in China and the UK, with links to JBI and Cochrane and covering animal as well as human health. The network seeks to capitalise on this unique position and to foster coordination and collaboration between all interested stakeholders.